The Procter & Gamble Company (NYSE:PG) Stock Holdings Decreased by PFS Partners LLC

PFS Partners LLC reduced its position in The Procter & Gamble Company (NYSE:PGFree Report) by 17.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 811 shares of the company’s stock after selling 172 shares during the period. PFS Partners LLC’s holdings in Procter & Gamble were worth $119,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the company. Emerald Advisors LLC boosted its holdings in Procter & Gamble by 1.8% during the fourth quarter. Emerald Advisors LLC now owns 3,775 shares of the company’s stock worth $553,000 after purchasing an additional 65 shares during the last quarter. O Brien Wealth Partners LLC boosted its holdings in Procter & Gamble by 3.3% during the fourth quarter. O Brien Wealth Partners LLC now owns 2,062 shares of the company’s stock worth $302,000 after purchasing an additional 65 shares during the last quarter. Proquility Private Wealth Partners LLC raised its position in Procter & Gamble by 1.1% during the second quarter. Proquility Private Wealth Partners LLC now owns 6,008 shares of the company’s stock worth $912,000 after acquiring an additional 66 shares in the last quarter. KFA Private Wealth Group LLC raised its position in Procter & Gamble by 2.2% during the third quarter. KFA Private Wealth Group LLC now owns 3,054 shares of the company’s stock worth $445,000 after acquiring an additional 67 shares in the last quarter. Finally, Chemistry Wealth Management LLC raised its position in Procter & Gamble by 1.2% during the fourth quarter. Chemistry Wealth Management LLC now owns 5,839 shares of the company’s stock worth $856,000 after acquiring an additional 67 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on PG. The Goldman Sachs Group assumed coverage on shares of Procter & Gamble in a research report on Friday, March 1st. They set a “neutral” rating and a $168.00 price target on the stock. Wells Fargo & Company increased their price objective on shares of Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a research report on Wednesday, January 24th. Truist Financial raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and increased their price objective for the company from $160.00 to $175.00 in a research report on Monday, March 11th. StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Finally, Raymond James raised their price target on shares of Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 24th. Seven investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $168.35.

Read Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Stock Down 0.3 %

NYSE PG traded down $0.39 during mid-day trading on Friday, hitting $155.45. The company’s stock had a trading volume of 925,475 shares, compared to its average volume of 6,794,954. The company has a current ratio of 0.64, a quick ratio of 0.44 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $365.78 billion, a price-to-earnings ratio of 26.04, a PEG ratio of 3.21 and a beta of 0.44. The company’s 50 day simple moving average is $159.38 and its 200 day simple moving average is $152.54. The Procter & Gamble Company has a twelve month low of $141.45 and a twelve month high of $163.14.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings data on Tuesday, January 23rd. The company reported $1.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.70 by $0.14. The firm had revenue of $21.44 billion for the quarter, compared to the consensus estimate of $21.48 billion. Procter & Gamble had a net margin of 17.60% and a return on equity of 34.04%. The business’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.59 EPS. Analysts anticipate that The Procter & Gamble Company will post 6.45 earnings per share for the current year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a $1.0065 dividend. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.59%. The ex-dividend date of this dividend is Thursday, April 18th. Procter & Gamble’s payout ratio is 62.98%.

Insider Activity at Procter & Gamble

In related news, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the sale, the chief executive officer now directly owns 4,859 shares in the company, valued at approximately $768,256.49. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CEO R. Alexandra Keith sold 776 shares of the company’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the sale, the chief executive officer now directly owns 4,859 shares in the company, valued at $768,256.49. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider Susan Street Whaley sold 3,865 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $160.60, for a total transaction of $620,719.00. Following the completion of the transaction, the insider now owns 11,886 shares in the company, valued at $1,908,891.60. The disclosure for this sale can be found here. In the last three months, insiders have sold 279,063 shares of company stock worth $43,187,745. Company insiders own 0.17% of the company’s stock.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.